{{Rsnum
|rsid=756529
|Gene=KCNB1
|Chromosome=20
|position=49394471
|Orientation=plus
|GMAF=0.4715
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=KCNB1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 48.7 | 32.7
| HCB | 40.9 | 40.9 | 18.2
| JPT | 38.1 | 40.7 | 21.2
| YRI | 15.6 | 55.8 | 28.6
| ASW | 19.3 | 50.9 | 29.8
| CHB | 40.9 | 40.9 | 18.2
| CHD | 28.4 | 49.5 | 22.0
| GIH | 23.8 | 38.6 | 37.6
| LWK | 28.2 | 51.8 | 20.0
| MEX | 19.3 | 54.4 | 26.3
| MKK | 23.1 | 51.3 | 25.6
| TSI | 14.7 | 39.2 | 46.1
| HapMapRevision=28
}}[http://7thspace.com/headlines/309687/genome_wide_association_study_identifies_single_nucleotide_polymorphism_in_kcnb1_associated_with_left_ventricular_mass_in_humans_the_hypergen_study.html news] suggest KCNB1 may be involved in the development of LV hypertrophy in humans.

{{PMID Auto
|PMID=19454037
|Title=Genome-wide association study identifies single-nucleotide polymorphism in KCNB1 associated with left ventricular mass in humans: The HyperGEN Study
|OA=1
}}

{{PMID Auto
|PMID=18466599
|Title=Linkage studies of catechol-O-methyltransferase (COMT) and dopamine-beta-hydroxylase (DBH) cDNA expression levels.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}